Healthcare - Biotechnology - NASDAQ - US
$ 2.15
-7.73 %
$ 9.84 M
Market Cap
-0.12
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
21.81%
EBIT
Estimate
79.76%
Net Income
Estimate
47.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Senti Biosciences, Inc.
SNTI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SNTI
EBIT FORECAST
EBIT Forecast Chart SNTI
NET INCOME FORECAST
Net Income Chart SNTI